Banard Charlene A. 4
4 · Applied Molecular Transport Inc. · Filed Dec 28, 2023
Insider Transaction Report
Form 4
Banard Charlene A.
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2023-12-27−60,000→ 0 totalExercise: $7.52Exp: 2032-03-31→ Common Stock (60,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-12-27−20,000→ 0 totalExercise: $0.34Exp: 2033-06-14→ Common Stock (20,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-12-27−20,000→ 0 totalExercise: $3.13Exp: 2032-05-24→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]Pursuant to the Agreement and Plan of Merger dated as of September 21, 2023 (the "Merger Agreement"), by and among Cyclo Therapeutics, Inc. ("Cyclo"), Cameo Merger Sub, Inc. and the Issuer, at the effective time of the Merger, each outstanding option with an exercise price of $0.40 or more was cancelled effective as of the closing.
- [F2]Pursuant to the terms of the Merger, this option was exchanged for an option covering 2,662 shares of Cyclo Common Stock.